环境真菌致敏与慢阻肺较差临床结局相关
该研究前瞻性纳入446例稳定期慢阻肺患者和51例非疾病对照,在三个国家筛查包括真菌在内的综合过敏原,并用宏基因组学评估室内外环境过敏原暴露。结果显示真菌致敏在慢阻肺中常见,与频繁急性加重相关,无监督聚类识别出「高度致敏真菌为主」亚组,其症状重、肺功能差,室内高真菌过敏原与更重症状和更差肺功能相关。
要点
- 真菌致敏在慢阻肺中常见,并与频繁急性加重相关,可能是可治疗特质。
- 无监督聚类识别出高度致敏真菌为主亚组,症状重、急性加重频繁且肺功能差。
- 室内外环境是真菌过敏原重要来源,室内高真菌过敏原与更重症状和更差肺功能相关。
核心结论
- 真菌致敏在慢阻肺中普遍存在并与频繁急性加重相关,代表潜在可治疗特质。
- 室内外环境是真菌过敏原暴露的关键来源,在致敏慢阻肺患者中可干预。
研究设计与样本
- 前瞻性研究纳入稳定期慢阻肺患者446例和非疾病对照51例,来自新加坡、马来西亚和香港三个国家。
- 采用宏基因组学方法评估慢阻肺患者室外和室内环境过敏原暴露。
- 对11例慢阻肺患者家庭室内空气和表面过敏原进行前瞻性宏基因组学评估并关联临床结局。
主要发现
- 慢阻肺患者对广谱过敏原存在高频率致敏。
- 真菌致敏与频繁急性加重相关。
- 无监督聚类揭示高度致敏真菌为主亚组,表现为明显症状、频繁急性加重和肺功能差。
- 室外和室内环境是真菌过敏原暴露的重要储备库,并促进对室外空气真菌的致敏反应。
- 室内家庭环境高真菌过敏原与更重慢阻肺症状和更差肺功能相关。
临床怎么用
- 对慢阻肺患者可考虑评估真菌致敏,作为识别频繁急性加重风险的可治疗特质。
- 关注室内环境真菌过敏原暴露,或可作为致敏慢阻肺患者可干预的管理靶点。
局限性
- 室内空气和表面过敏原前瞻性评估仅限11例慢阻肺患者家庭,样本量小。
- 研究为观察性设计,环境暴露与临床结局的关联不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Allergic sensitisation to fungi such as Aspergillus are associated to poor clinical outcomes in asthma, bronchiectasis and cystic fibrosis; however, clinical relevance in COPD remains unclear. METHODS: Patients with stable COPD (n=446) and nondiseased controls (n=51) were prospectively recruited across three countries (Singapore, Malaysia and Hong Kong) and screened against a comprehensive allergen panel including house dust mites, pollens, cockroach and fungi. For the first time, using a metagenomics approach, we assessed outdoor and indoor environmental allergen exposure in COPD. We identified key fungi in outdoor air and developed specific-IgE assays against the top culturable fungi, linking sensitisation responses to COPD outcomes. Indoor air and surface allergens were prospectively evaluated by metagenomics in the homes of 11 COPD patients and linked to clinical outcome. RESULTS: High frequencies of sensitisation to a broad range of allergens occur in COPD. Fungal sensitisation associates with frequent exacerbations, and unsupervised clustering reveals a "highly sensitised fungal predominant" subgroup demonstrating significant symptomatology, frequent exacerbations and poor lung function. Outdoor and indoor environments serve as important reservoirs of fungal allergen exposure in COPD and promote a sensitisation response to outdoor air fungi. Indoor (home) environments with high fungal allergens associate with greater COPD symptoms and poorer lung function, illustrating the importance of environmental exposures on clinical outcomes in COPD. CONCLUSION: Fungal sensitisation is prevalent in COPD and associates with frequent exacerbations representing a potential treatable trait. Outdoor and indoor (home) environments represent a key source of fungal allergen exposure, amenable to intervention, in "sensitised" COPD.
引用
- Tiew PY, Ko FWS, Pang SL, et al. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. Eur Respir J. 2020. PMID: 32341102. doi:10.1183/13993003.00418-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。